Axovant Sciences to Present at Upcoming Investor Conferences
June 7at 2:00 p.m. ETat the Jefferies2017 Healthcare Conference June 21at 11:00 a.m. ETat the JMP Securities Life Science Conference
A simultaneous webcast will be available for each conference in the Investors section of Axovant's website at www.axovant.com. A replay will be available for 30 days following each conference.
Axovant is a clinical-stage company focused on developing and commercializing innovative medicines that broadly address multiple forms of dementia and related neurological disorders. Axovant is developing a pipeline of late- and early-stage product candidates that focuses on the cognitive, functional, and behavioral aspects of debilitating conditions such as Alzheimer's disease and Lewy body dementia and related states. For more information, visit www.axovant.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/axovant-sciences-to-present-at-upcoming-investor-conferences-300466559.html
Jonathan Neely, Head, Investor Relations, Axovant Sciences, Inc., (212) 634-9744